Sri Lanka to study Molnupiravir to treat symptomatic COVID - 19
Occurred in Sri Lanka on Nov. 6, 2021 at 5:42 p.m.
Reported by Saahithiyanan Ganeshanathan via Internet on Nov. 7, 2021 at 2:36 p.m.
Reported by Saahithiyanan Ganeshanathan via Internet on Nov. 7, 2021 at 2:36 p.m.
# COVID-19
# cure
This report is Confirmed true
and is of
Low Priority.
Here is why -
The State Ministry of Production, Supply and Regulation of Pharmaceuticals has focused its attention on the use of ‘Molnupiravir’ in Molnupiravir, developed by the US drug companies Merck, Sharp and Dohme (MSD) and Ridgeback Biotherapeutics, is the first antiviral medication for Covid which can be taken as a pill rather than injected or given intravenously.Sri Lanka, against COVID-19.Meanwhile, the Sri Lankan Health Ministry said in a statement that it had requested the COVID-19 expert committee to inquire into the drug and provide recommendations in the near future.
Resolution added by - Saahithiyanan Ganeshanathan